BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 32737707)

  • 1. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2021 Jan; 37(1):255-266. PubMed ID: 32737707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Cheng ASH; Singh A; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 Jan; 36(1):101-110. PubMed ID: 31401742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Right ventricular function in heart failure with preserved ejection fraction: a community-based study.
    Mohammed SF; Hussain I; AbouEzzeddine OF; Takahama H; Kwon SH; Forfia P; Roger VL; Redfield MM
    Circulation; 2014 Dec; 130(25):2310-20. PubMed ID: 25391518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-study and inter-technique validation of cardiovascular magnetic resonance imaging derived left atrial ejection fraction as a prognostic biomarker in heart failure with preserved ejection fraction.
    Kanagala P; Arnold JR; Singh A; Khan JN; Gulsin GS; Gupta P; Squire IB; Ng LL; McCann GP
    Int J Cardiovasc Imaging; 2020 May; 36(5):921-928. PubMed ID: 32030576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in heart failure with preserved ejection fraction - implications for clinical trials.
    Kanagala P; Cheng ASH; Singh A; McAdam J; Marsh AM; Arnold JR; Squire IB; Ng LL; McCann GP
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):4. PubMed ID: 29321034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Importance of Right Ventricular-Vascular Uncoupling in Acute Decompensated Heart Failure With Preserved Ejection Fraction.
    Nakagawa A; Yasumura Y; Yoshida C; Okumura T; Tateishi J; Yoshida J; Abe H; Tamaki S; Yano M; Hayashi T; Nakagawa Y; Yamada T; Nakatani D; Hikoso S; Sakata Y
    Circ Cardiovasc Imaging; 2020 Nov; 13(11):e011430. PubMed ID: 33198494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right heart dysfunction in heart failure with preserved ejection fraction.
    Melenovsky V; Hwang SJ; Lin G; Redfield MM; Borlaug BA
    Eur Heart J; 2014 Dec; 35(48):3452-62. PubMed ID: 24875795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Value of Pulmonary Transit Time by Cardiac Magnetic Resonance on Mortality and Heart Failure Hospitalization in Patients With Advanced Heart Failure and Reduced Ejection Fraction.
    Houard L; Amzulescu MS; Colin G; Langet H; Militaru S; Rousseau MF; Ahn SA; Vanoverschelde JJ; Pouleur AC; Gerber BL
    Circ Cardiovasc Imaging; 2021 Jan; 14(1):e011680. PubMed ID: 33438438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Atrial Phasic Function in Heart Failure With Preserved and Reduced Ejection Fraction.
    Jain S; Kuriakose D; Edelstein I; Ansari B; Oldland G; Gaddam S; Javaid K; Manaktala P; Lee J; Miller R; Akers SR; Chirinos JA
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 1):1460-1470. PubMed ID: 30343071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction.
    Garg P; Lewis RA; Johns CS; Swift AJ; Capener D; Rajaram S; Thompson AAR; Condliffe R; Elliot CA; Charalampopoulos A; Hameed AG; Rothman A; Wild JM; Kiely DG
    Int J Cardiovasc Imaging; 2021 Oct; 37(10):3019-3025. PubMed ID: 33978936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction.
    Zakeri R; Mohammed SF
    Curr Heart Fail Rep; 2015 Oct; 12(5):295-301. PubMed ID: 26338372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing heart failure with preserved and reduced ejection fraction: An imaging and plasma biomarker approach.
    Kanagala P; Arnold JR; Singh A; Chan DCS; Cheng ASH; Khan JN; Gulsin GS; Yang J; Zhao L; Gupta P; Squire IB; Ng LL; McCann GP
    PLoS One; 2020; 15(4):e0232280. PubMed ID: 32349122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RV Contractile Function and its Coupling to Pulmonary Circulation in Heart Failure With Preserved Ejection Fraction: Stratification of Clinical Phenotypes and Outcomes.
    Guazzi M; Dixon D; Labate V; Beussink-Nelson L; Bandera F; Cuttica MJ; Shah SJ
    JACC Cardiovasc Imaging; 2017 Oct; 10(10 Pt B):1211-1221. PubMed ID: 28412423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of Echocardiographic Characteristics of the Right-Sided Heart With Incident Heart Failure and Mortality in Patients With Sleep-Disordered Breathing and Preserved Left Ventricular Ejection Fraction.
    Kusunose K; Phelan D; Seicean S; Seicean A; Collier P; Boden KA; Mehra R; Griffin BP
    Am J Cardiol; 2016 Oct; 118(8):1268-1273. PubMed ID: 27553095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.